Teacher Retirement System of Texas’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-994
Closed -$72K 1940
2023
Q1
$72K Buy
994
+17
+2% +$1.65K ﹤0.01% 2010
2022
Q4
$80K Sell
977
-57
-6% -$5.94K ﹤0.01% 1985
2022
Q3
$98K Buy
1,034
+550
+114% +$61.8K ﹤0.01% 2058
2022
Q2
$94K Sell
484
-134
-22% -$21.9K ﹤0.01% 1831
2022
Q1
$144K Buy
618
+69
+13% +$22K ﹤0.01% 2018
2021
Q4
$216K Buy
549
+91
+20% +$38.3K ﹤0.01% 1973
2021
Q3
$205K Buy
+458
New +$164K ﹤0.01% 1898
2018
Q3
Sell
-244
Closed -$225K 1581
2018
Q2
$225K Sell
244
-23
-9% -$24.7K ﹤0.01% 1721
2018
Q1
$260K Buy
+267
New +$243K ﹤0.01% 1619
2016
Q3
Sell
-96
Closed -$54K 1450
2016
Q2
$54K Buy
96
+12
+14% +$5.76K ﹤0.01% 2191
2016
Q1
$40K Buy
84
+21
+33% +$9.45K ﹤0.01% 2260
2015
Q4
$42K Sell
63
-19
-23% -$14.4K ﹤0.01% 2152
2015
Q3
$65K Buy
82
+63
+332% +$76.8K ﹤0.01% 1993
2015
Q2
$25K Buy
+19
New +$21.8K ﹤0.01% 1964

Other funds holding ATRA

Teacher Retirement System of Texas's ATRA Position: Q2 2023 in Review

Teacher Retirement System of Texas sold out of Atara Biotherapeutics (ATRA) in Q2 2023, closing a stake of 994 shares — an estimated $72K sold.

Teacher Retirement System of Texas first reported a position in ATRA in Q2 2015 and held it in 14 quarters. The position peaked at $260K in Q1 2018. 118 funds tracked by Wall St. Rank hold ATRA as of Q2 2023.

  • Teacher Retirement System of Texas reported no remaining Atara Biotherapeutics position as of Q2 2023 after selling out during the quarter.
  • Teacher Retirement System of Texas sold 994 Atara Biotherapeutics shares in Q2 2023, an estimated $72K.
  • Teacher Retirement System of Texas first reported a position in Atara Biotherapeutics in Q2 2015 and held it in 14 quarters.
  • Teacher Retirement System of Texas's Atara Biotherapeutics position peaked at $260K in Q1 2018.
  • 118 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2023.

Based on Teacher Retirement System of Texas's 13F filing for Q2 2023, filed 17 Jul 2023.